genia tagger: 158('limited', 10)
('proposed', 2)
('probe', 12)
('results', 11)
('hela', 4)
('human', 16)
('amplified', 8)
('primer', 22)
('regions', 6)
('kif1a', 25)
('transcriptase', 2)
('\\>', 4)
('\\?', 13)
('mcf-7', 22)
('mda-mb-436', 6)
('her-2', 4)
('\\%', 68)
('4', 223)
('400', 2)
('\\,', 339)
('suppressor', 9)
('\\(', 300)
('\\)', 300)
('mda-mb-231', 18)
('putative', 1)
('histone', 4)
('epigenetically', 4)
('rna', 28)
('forty-nine', 1)
('dna\\.', 6)
('five', 23)
('breast', 150)
('using', 18)
('ogdhl', 13)
('gel', 6)
('pbs', 2)
('bn7', 4)
('l', 2039)
('bn4', 4)
('mrna', 12)
('female', 8)
('reference', 2)
('sequence', 22)
('proteins', 8)
('nonneoplastic', 4)
('genes\\.', 17)
('age-matched', 14)
('50', 8)
('fkbp4', 53)
('surrounding', 4)
('design', 15)
('genomic', 6)
('electrophoresis\\.', 2)
('msp\\.', 4)
('candidate', 21)
('sites', 4)
('cell', 147)
('deacetylase', 4)
('3', 182)
('inactivated', 3)
('7', 62)
('activity\\.', 4)
('glyceraldehyde-3-phosphate', 2)
('genes', 184)
('androgen', 16)
('fig\\.', 12)
('steroid', 8)
('7900', 2)
('g\\/ml', 2)
('bt-20', 6)
('bisulfite-modified', 4)
('38', 30)
('folding', 4)
('reverse', 12)
('island', 6)
('region', 8)
('tumor', 143)
('pcr', 18)
('negative', 18)
('products', 4)
('2\\.2\\.1', 2)
('x-chromosome', 12)
('gene', 252)
('bisulfite', 35)
('cis-trans', 4)
('neoplastic', 14)
('wdr45', 8)
('cancer', 144)
('transcription-pcr', 6)
('locus', 4)
('receptor', 52)
('another', 12)
('sequences', 4)
('table', 52)
('dehydrogenase', 2)
('dna', 55)
('positive', 22)
('triplicate', 6)
('two', 37)
('msp', 26)
('start', 2)
('cancer\\.', 15)
('methylated', 147)
('2cen-q13', 4)
('immunophilin', 4)
('silenced', 1)
('factor', 4)
('dinucleotides\\.', 2)
('particular', 4)
('novel', 13)
('18', 2)
('cells', 51)
('promoter', 47)
('cdna', 2)
('tumor-suppressive', 4)
('transcripts', 2)
('and', 273)
('transcriptional', 2)
('estrogen', 32)
('site', 6)
('ii', 2)
('protein', 18)
('proteinase', 2)
('chromosome', 16)
('49', 8)
('vgf', 33)
('sds', 4)
('1', 161)
('microarray', 25)
('5', 92)
('fas', 4)
('9', 62)
('actb', 6)
('reexpressed', 4)
('isomerase', 4)
('literature', 4)
('normal', 81)
('promoters', 6)
('agarose', 2)
('tissues\\.', 21)
('complexes', 4)
('cancer-specific', 31)
('peptidyl-prolyl', 4)
('fkbp', 57)
('mal', 156)
('types', 8)
('78', 10)
('2', 149)
('primers', 16)
('lines', 57)
('gapdh', 2)
('analysis\\.', 5)
('cpg', 16)
('wd-repeat', 4)
('experimental', 5)
('search\\.', 4)
('discussion', 6)
('superscript', 2)


spacy + metamap: 426('limited', 10)
('focus', 4)
('four', 10)
('subclass', 4)
('adjustment', 2)
('cases', 8)
('amplification', 4)
('kif1a', 25)
('epithelial cells', 2)
('histone deacetylase inhibitors', 4)
('androgen receptor protein', 4)
('cdna', 2)
('apoptosis', 8)
('condition', 6)
('malignant disease', 4)
('severely', 4)
('pbs', 2)
('cpg dinucleotide', 2)
('shock', 4)
('candidate genes', 8)
('large', 12)
('multiple markers', 4)
('trp', 4)
('cell lines', 56)
('genechip', 4)
('triplicate', 6)
('consistent', 12)
('fkbp4', 53)
('surrounding', 4)
('microarray analysis', 10)
('value', 6)
('matched normal tissue', 8)
('tumorigenicity', 4)
('primer', 22)
('hormonal', 4)
('current', 4)
('template', 2)
('new', 21)
('mammography', 4)
('publications', 4)
('agarose gel electrophoresis', 2)
('genes', 184)
('component', 4)
('normal tissue', 24)
('water', 2)
('reported', 4)
('ethanol', 2)
('excess', 2)
('ratio', 22)
('search', 8)
('study', 18)
('larger', 4)
('approaches', 12)
('dna methylation', 4)
('products', 4)
('gene', 252)
('studies', 24)
('bisulfite', 35)
('highly', 4)
('decrease', 8)
('marker', 53)
('tumor sample', 4)
('total', 6)
('aberrant', 5)
('bisulfite sequencing', 14)
('conventional', 3)
('dna', 55)
('positive', 22)
('two', 37)
('few', 4)
('panel', 16)
('type', 18)
('more', 26)
('0\\%', 14)
('immunophilin', 4)
('females', 4)
('colon cancer', 4)
('excellent', 8)
('known', 7)
('ward', 6)
('effort', 4)
('xp11\\.23', 4)
('glyceraldehyde-3-phosphate dehydrogenase', 2)
('mb', 46)
('package', 2)
('modified', 4)
('androgen receptor signaling pathway', 4)
('values', 2)
('temperatures', 2)
('male', 16)
('example', 4)
('history', 2)
('control', 10)
('estradiols', 4)
('agent', 4)
('sample', 44)
('cellular function', 4)
('human breast cancer cell', 6)
('serial', 2)
('information', 4)
('s3', 2)
('s2', 2)
('discussion', 6)
('serum', 8)
('prognosis', 4)
('actb', 6)
('matched tissues', 2)
('pathway', 8)
('stock', 2)
('blanks', 2)
('mal gene', 4)
('invasion', 4)
('data', 12)
('mal', 156)
('summarization', 2)
('lines', 57)
('5-aza', 26)
('breast tissue sample', 4)
('s1', 2)
('superscript', 2)
('androgen receptor', 12)
('primary tumors', 14)
('estrogen receptor negative', 4)
('pcr', 18)
('internal control', 2)
('cell differentiation antigen', 4)
('fig', 12)
('gel', 6)
('good', 4)
('diseases', 8)
('combination', 8)
('demographics', 2)
('males', 8)
('number', 10)
('high frequency', 5)
('association', 4)
('matched', 14)
('progression', 4)
('l-', 11)
('proteins', 8)
('identified', 38)
('repeating', 4)
('characterized', 6)
('development', 9)
('neoplastic cells', 8)
('micrograms', 2)
('gene transcription', 4)
('mda', 24)
('primary breast cancers', 2)
('frequency', 21)
('breast tissue', 22)
('20\\%', 4)
('increase', 32)
('\\/l', 2)
('newly', 4)
('asp', 8)
('tumor markers', 8)
('completely', 6)
('methylation', 144)
('mrna expression', 4)
('wdr45', 8)
('primary', 32)
('one', 26)
('steroid hormone receptor', 4)
('defects', 4)
('specificity', 4)
('array', 29)
('stage', 8)
('system', 10)
('response', 4)
('methylated', 147)
('motility', 4)
('genomic dna', 4)
('tumor suppressor genes', 1)
('signaling', 8)
('relative', 6)
('target', 4)
('instruction', 6)
('preparation', 2)
('patients', 16)
('future', 4)
('sera', 4)
('treated', 9)
('mini', 6)
('hypermethylation', 9)
('leukocyte', 6)
('100\\%', 4)
('reverse transcription', 6)
('vgf', 33)
('dilutions', 2)
('breast cancers', 7)
('potential', 16)
('dna sequencing', 1)
('detector', 4)
('multiple', 6)
('supplementary material', 2)
('normal', 81)
('most', 8)
('eukaryotes', 4)
('probes', 6)
('average', 4)
('disease', 9)
('rna probe', 2)
('methyltransferase', 2)
('probe', 12)
('solutions', 2)
('threshold', 4)
('advanced stage', 4)
('based', 28)
('maturation', 4)
('only', 13)
('actin', 2)
('factor', 4)
('various', 25)
('normal breast', 17)
('plate', 8)
('gemcitabine', 4)
('sss', 2)
('cpg island', 6)
('abnormally high', 4)
('breast', 150)
('dye', 2)
('ogdhl', 13)
('untreated', 2)
('cell pellet', 2)
('organ', 2)
('tumors', 82)
('alteration', 8)
('summary', 2)
('sequence analysis', 12)
('activity', 8)
('set', 22)
('reference', 2)
('sensitivity', 12)
('detection', 22)
('culture', 4)
('individual', 6)
('result', 11)
('estrogen receptor', 32)
('reverse transcriptase', 2)
('trizol', 2)
('pattern', 4)
('sites', 4)
('artificial', 4)
('tumor suppressor', 9)
('identification', 4)
('normal control', 2)
('approach', 21)
('therapies', 4)
('wd', 20)
('nipple aspirate fluid', 4)
('x-chromosome genes', 8)
('suppresses', 4)
('analyzer', 2)
('mrna stability', 4)
('reaction', 4)
('folding', 4)
('blood test', 4)
('48 hours', 4)
('region', 8)
('sensitive', 4)
('negative', 18)
('expression', 55)
('neoplastic', 14)
('cancer', 144)
('human gene', 2)
('mutations', 4)
('sequences', 4)
('table', 52)
('addition', 16)
('tumor marker', 16)
('quantile', 2)
('three', 12)
('strategy', 4)
('extraction', 6)
('interest', 12)
('dna extraction', 2)
('efficacy', 4)
('mcf', 22)
('24 hours', 4)
('al', 428)
('up-regulation', 4)
('applied', 8)
('novel', 13)
('promoter', 47)
('transcripts', 2)
('demethylation', 4)
('vesicle fusion', 4)
('cell growth', 4)
('tissue', 76)
('terminator', 2)
('breast cancer cell', 19)
('protein', 18)
('cohort', 8)
('different', 6)
('transmembrane', 4)
('same', 4)
('microarray', 25)
('microdissection', 4)
('esophageal cancer', 4)
('phenotype', 4)
('modification', 6)
('plates', 2)
('several', 9)
('mrna modification', 4)
('status', 6)
('literature', 4)
('promoters', 6)
('chloroform', 2)
('kit', 4)
('american type culture collection', 2)
('levels', 10)
('purpose', 1)
('robust', 4)
('normalization', 2)
('recent', 4)
('lower', 4)
('in vitro', 4)
('surrogate', 4)
('well', 18)
('analysis', 37)
('materials', 1)
('quantitative', 9)
('proposed', 2)
('50\\%', 4)
('human', 16)
('alternative', 4)
('previous', 38)
('conclusions', 1)
('cell fate determination', 4)
('treatment', 29)
('easy', 2)
('relevance', 4)
('instructions', 4)
('plasma', 12)
('remaining', 4)
('hybridization', 2)
('tests', 4)
('rna', 28)
('experimental design', 1)
('five', 23)
('background', 2)
('mol', 2)
('precipitation', 2)
('malignancy', 2)
('specific', 51)
('candidate tumor suppressor gene', 4)
('reduced', 4)
('a t', 10)
('methods', 5)
('sequence', 22)
('cell line', 62)
('prokaryotes', 4)
('subtypes', 4)
('fluids', 4)
('pathogenesis', 9)
('tissue sample', 16)
('moderate', 4)
('gene expression', 8)
('minimal', 4)
('bd', 2)
('biology', 1)
('epigenetic', 8)
('patient', 20)
('step', 4)
('bp', 61)
('g\\/ml', 2)
('manufacturer', 4)
('complexes', 4)
('new england', 2)
('wd-repeat protein', 4)
('tumor', 143)
('hela cells', 4)
('concentrations', 4)
('silence', 1)
('early cancer detection', 4)
('presence', 12)
('locus', 4)
('involvement', 4)
('female', 8)
('esophageal squamous cell carcinoma', 4)
('utility', 4)
('tumorigenesis', 4)
('additional', 8)
('cell division', 4)
('luminal', 4)
('clinical', 8)
('breast cancer', 76)
('medium', 4)
('sds', 4)
('70\\%', 2)
('level', 12)
('cancer cell', 23)
('t-cell differentiation', 4)
('aza', 26)
('cells', 51)
('cancers', 8)
('lymph node metastasis', 4)
('distribution', 2)
('units', 4)
('estrogen', 32)
('receptor expression', 4)
('tissues', 55)
('2cen-q13', 4)
('proven', 4)
('proteinase', 2)
('chromosome', 16)
('calibration', 2)
('steroid receptor', 4)
('inactivation', 8)
('ng', 155)
('role', 12)
('phenol', 2)
('test', 41)
('diagnostic marker', 5)
('important', 12)
('fkbp', 57)
('pharmacologic', 6)
('fluorescence', 2)
('age', 48)
('curve', 2)
('gapdh', 2)
('cpg', 16)
('portion', 2)
('early detection', 12)
('validation', 4)


total: 517('limited', 10)
('excellent', 8)
('results', 11)
('four', 10)
('subclass', 4)
('amplified', 8)
('primer', 22)
('ward', 6)
('amplification', 4)
('kif1a', 25)
('epithelial cells', 2)
('histone deacetylase inhibitors', 4)
('mda-mb-436', 6)
('androgen receptor protein', 4)
('cdna', 2)
('fas', 4)
('focus', 4)
('condition', 6)
('malignant disease', 4)
('severely', 4)
('pbs', 2)
('cpg dinucleotide', 2)
('shock', 4)
('candidate genes', 8)
('large', 12)
('multiple markers', 4)
('trp', 4)
('cell lines', 56)
('genechip', 4)
('triplicate', 6)
('consistent', 12)
('age-matched', 14)
('fkbp4', 53)
('surrounding', 4)
('design', 15)
('value', 6)
('electrophoresis\\.', 2)
('matched normal tissue', 8)
('tumorigenicity', 4)
('adjustment', 2)
('hormonal', 4)
('cell', 147)
('template', 2)
('new', 21)
('mammography', 4)
('publications', 4)
('agarose gel electrophoresis', 2)
('genes', 184)
('component', 4)
('normal tissue', 24)
('water', 2)
('reported', 4)
('ethanol', 2)
('excess', 2)
('7900', 2)
('ratio', 22)
('bt-20', 6)
('search', 8)
('38', 30)
('study', 18)
('larger', 4)
('approaches', 12)
('dna methylation', 4)
('products', 4)
('2\\.2\\.1', 2)
('gene', 252)
('studies', 24)
('bisulfite', 35)
('transcription-pcr', 6)
('highly', 4)
('decrease', 8)
('marker', 53)
('tumor sample', 4)
('total', 6)
('aberrant', 5)
('bisulfite sequencing', 14)
('conventional', 3)
('dna', 55)
('x-chromosome', 12)
('negative', 18)
('msp', 26)
('few', 4)
('gemcitabine', 4)
('manufacturer', 4)
('type', 18)
('more', 26)
('0\\%', 14)
('immunophilin', 4)
('females', 4)
('colon cancer', 4)
('particular', 4)
('known', 7)
('cases', 8)
('effort', 4)
('xp11\\.23', 4)
('glyceraldehyde-3-phosphate dehydrogenase', 2)
('mb', 46)
('modified', 4)
('androgen receptor signaling pathway', 4)
('values', 2)
('temperatures', 2)
('tumor-suppressive', 4)
('male', 16)
('example', 4)
('history', 2)
('control', 10)
('estradiols', 4)
('agent', 4)
('sample', 44)
('cellular function', 4)
('serial', 2)
('human breast cancer cell', 6)
('information', 4)
('s3', 2)
('s2', 2)
('s1', 2)
('activity\\.', 4)
('serum', 8)
('regions', 6)
('prognosis', 4)
('apoptosis', 8)
('actb', 6)
('matched tissues', 2)
('pathway', 8)
('stock', 2)
('blanks', 2)
('agarose', 2)
('mal gene', 4)
('invasion', 4)
('data', 12)
('mal', 156)
('types', 8)
('summarization', 2)
('primers', 16)
('lines', 57)
('5-aza', 26)
('breast tissue sample', 4)
('discussion', 6)
('superscript', 2)
('androgen receptor', 12)
('primary tumors', 14)
('estrogen receptor negative', 4)
('hela', 4)
('1', 161)
('pcr', 18)
('internal control', 2)
('cell differentiation antigen', 4)
('fig', 12)
('400', 2)
('suppressor', 9)
('good', 4)
('diseases', 8)
('combination', 8)
('epigenetically', 4)
('demographics', 2)
('males', 8)
('primary', 32)
('modification', 6)
('association', 4)
('matched', 14)
('progression', 4)
('l-', 11)
('proteins', 8)
('l', 2039)
('mrna', 12)
('involvement', 4)
('repeating', 4)
('characterized', 6)
('development', 9)
('neoplastic cells', 8)
('micrograms', 2)
('gene transcription', 4)
('mda', 24)
('alteration', 8)
('primary breast cancers', 2)
('frequency', 21)
('msp\\.', 4)
('breast tissue', 22)
('20\\%', 4)
('increase', 32)
('inactivated', 3)
('7', 62)
('newly', 4)
('utility', 4)
('glyceraldehyde-3-phosphate', 2)
('asp', 8)
('tumor markers', 8)
('completely', 6)
('cell fate determination', 4)
('methylation', 144)
('target', 4)
('mrna expression', 4)
('purpose', 1)
('esophageal squamous cell carcinoma', 4)
('wdr45', 8)
('number', 10)
('one', 26)
('steroid hormone receptor', 4)
('defects', 4)
('another', 12)
('specificity', 4)
('array', 29)
('stage', 8)
('system', 10)
('response', 4)
('methylated', 147)
('motility', 4)
('genomic dna', 4)
('sensitivity', 12)
('tumor suppressor genes', 1)
('signaling', 8)
('relative', 6)
('cell pellet', 2)
('18', 2)
('instruction', 6)
('preparation', 2)
('patients', 16)
('future', 4)
('sera', 4)
('microarray analysis', 10)
('treated', 9)
('and', 273)
('mini', 6)
('hypermethylation', 9)
('medium', 4)
('analysis\\.', 5)
('leukocyte', 6)
('100\\%', 4)
('reverse transcription', 6)
('vgf', 33)
('dilutions', 2)
('breast cancers', 7)
('potential', 16)
('dna sequencing', 1)
('detector', 4)
('multiple', 6)
('supplementary material', 2)
('normal', 81)
('tissues\\.', 21)
('complexes', 4)
('cancer-specific', 31)
('peptidyl-prolyl', 4)
('probes', 6)
('2', 149)
('average', 4)
('disease', 9)
('rna probe', 2)
('methyltransferase', 2)
('probe', 12)
('solutions', 2)
('threshold', 4)
('advanced stage', 4)
('current', 4)
('based', 28)
('maturation', 4)
('only', 13)
('actin', 2)
('factor', 4)
('various', 25)
('normal breast', 17)
('plate', 8)
('histone', 4)
('sss', 2)
('forty-nine', 1)
('cpg island', 6)
('abnormally high', 4)
('breast', 150)
('dye', 2)
('ogdhl', 13)
('untreated', 2)
('gel', 6)
('organ', 2)
('tumors', 82)
('9', 62)
('summary', 2)
('sequence analysis', 12)
('activity', 8)
('set', 22)
('reference', 2)
('nonneoplastic', 4)
('detection', 22)
('culture', 4)
('individual', 6)
('result', 11)
('estrogen receptor', 32)
('genomic', 6)
('reverse transcriptase', 2)
('trizol', 2)
('pattern', 4)
('sites', 4)
('artificial', 4)
('tumor suppressor', 9)
('3', 182)
('identification', 4)
('normal control', 2)
('approach', 21)
('therapies', 4)
('wd', 20)
('nipple aspirate fluid', 4)
('x-chromosome genes', 8)
('suppresses', 4)
('analyzer', 2)
('androgen', 16)
('fig\\.', 12)
('steroid', 8)
('mrna stability', 4)
('reaction', 4)
('folding', 4)
('candidate', 21)
('blood test', 4)
('48 hours', 4)
('region', 8)
('sensitive', 4)
('expression', 55)
('wd-repeat', 4)
('cis-trans', 4)
('neoplastic', 14)
('cancer', 144)
('human gene', 2)
('mutations', 4)
('sequences', 4)
('table', 52)
('panel', 16)
('most', 8)
('addition', 16)
('tumor marker', 16)
('quantile', 2)
('three', 12)
('strategy', 4)
('extraction', 6)
('cancer\\.', 15)
('interest', 12)
('treatment', 29)
('dna extraction', 2)
('efficacy', 4)
('silenced', 1)
('mcf', 22)
('24 hours', 4)
('dinucleotides\\.', 2)
('up-regulation', 4)
('reverse', 12)
('applied', 8)
('novel', 13)
('promoter', 47)
('transcripts', 2)
('hybridization', 2)
('demethylation', 4)
('vesicle fusion', 4)
('cell growth', 4)
('site', 6)
('ii', 2)
('tissue', 76)
('terminator', 2)
('breast cancer cell', 19)
('protein', 18)
('cohort', 8)
('different', 6)
('transmembrane', 4)
('same', 4)
('microarray', 25)
('microdissection', 4)
('esophageal cancer', 4)
('phenotype', 4)
('high frequency', 5)
('plates', 2)
('several', 9)
('mrna modification', 4)
('status', 6)
('literature', 4)
('promoters', 6)
('chloroform', 2)
('kit', 4)
('american type culture collection', 2)
('levels', 10)
('two', 37)
('robust', 4)
('normalization', 2)
('recent', 4)
('lower', 4)
('in vitro', 4)
('surrogate', 4)
('calibration', 2)
('well', 18)
('analysis', 37)
('materials', 1)
('reexpressed', 4)
('quantitative', 9)
('proposed', 2)
('mda-mb-231', 18)
('50\\%', 4)
('human', 16)
('alternative', 4)
('previous', 38)
('transcriptase', 2)
('conclusions', 1)
('\\>', 4)
('\\?', 13)
('mcf-7', 22)
('her-2', 4)
('\\%', 68)
('4', 223)
('easy', 2)
('relevance', 4)
('role', 12)
('\\,', 339)
('instructions', 4)
('plasma', 12)
('remaining', 4)
('\\(', 300)
('\\)', 300)
('tests', 4)
('putative', 1)
('rna', 28)
('experimental design', 1)
('dna\\.', 6)
('five', 23)
('background', 2)
('mol', 2)
('using', 18)
('precipitation', 2)
('malignancy', 2)
('bn7', 4)
('50', 8)
('bn4', 4)
('specific', 51)
('candidate tumor suppressor gene', 4)
('reduced', 4)
('a t', 10)
('methods', 5)
('sequence', 22)
('cell line', 62)
('identified', 38)
('prokaryotes', 4)
('subtypes', 4)
('fluids', 4)
('pathogenesis', 9)
('deacetylase', 4)
('tissue sample', 16)
('moderate', 4)
('gene expression', 8)
('minimal', 4)
('bd', 2)
('biology', 1)
('epigenetic', 8)
('patient', 20)
('step', 4)
('bp', 61)
('g\\/ml', 2)
('bisulfite-modified', 4)
('package', 2)
('island', 6)
('new england', 2)
('wd-repeat protein', 4)
('tumor', 143)
('hela cells', 4)
('positive', 22)
('concentrations', 4)
('silence', 1)
('early cancer detection', 4)
('eukaryotes', 4)
('presence', 12)
('al', 428)
('locus', 4)
('receptor', 52)
('female', 8)
('\\/l', 2)
('dehydrogenase', 2)
('tumorigenesis', 4)
('additional', 8)
('cell division', 4)
('luminal', 4)
('start', 2)
('clinical', 8)
('78', 10)
('breast cancer', 76)
('genes\\.', 17)
('sds', 4)
('70\\%', 2)
('level', 12)
('cancer cell', 23)
('t-cell differentiation', 4)
('aza', 26)
('cells', 51)
('experimental', 5)
('cancers', 8)
('lymph node metastasis', 4)
('distribution', 2)
('units', 4)
('transcriptional', 2)
('estrogen', 32)
('receptor expression', 4)
('tissues', 55)
('2cen-q13', 4)
('proven', 4)
('proteinase', 2)
('chromosome', 16)
('49', 8)
('steroid receptor', 4)
('inactivation', 8)
('isomerase', 4)
('ng', 155)
('5', 92)
('phenol', 2)
('test', 41)
('diagnostic marker', 5)
('important', 12)
('fkbp', 57)
('pharmacologic', 6)
('fluorescence', 2)
('age', 48)
('curve', 2)
('gapdh', 2)
('cpg', 16)
('portion', 2)
('early detection', 12)
('search\\.', 4)
('validation', 4)
